Tempest Therapeutics Inc. Common Stock (TPST)
Stock · NASDAQ · Health Care
$1.06as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
About TPST
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 5
- Website
- www.tempesttx.com
Fundamentals
- 1-day range
- $0.9025$0.9298
- Market cap
- $14.42M
- P/E (trailing)
- —
- P/E (forward)
- -0.76
- EPS (trailing)
- $-5.70
- Dividend yield
- —
- Beta
- -1.68
- Avg. volume
- 152.6K
- Dividend pay date
- December 10, 2018
How Tempest Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2017 annual results
Source: 10-K filed Mar 15, 2018 · via SEC EDGAR / Finnhub
Tempest Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TPSTTempest Therapeutics Inc. Common Stock$1.06▼ 1.85%Market cap $14.42MP/E —$0.84$12.23
- COCPCocrystal Pharma Inc. Common Stock$1.11▼ 2.63%Market cap $14.20MP/E —$0.76$2.67
- AKTXAkari Therapeutics plc ADS$11.03▲ 22.42%Market cap $14.14MP/E Infinity$3.02$49.6
- KTTAPasithea Therapeutics Corp. Common Stock$0.5975▲ 7.66%Market cap $14.82MP/E —$0.281$2.06
- HINDVyome Holdings Inc. Common Stock$2.2▼ 0.23%Market cap $15.02MP/E —$1.75$10.97
- AEONAEON Biopharma Inc. Class A Common Stock$0.3095▲ 5.27%Market cap $13.80MP/E —$0.1772$1.45
- SCNXScienture Holdings Inc. Common Stock$0.3938▲ 3.63%Market cap $15.14MP/E —$0.2382$2.6
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TPST Tempest Therapeutics Inc. Common Stock | $14.42M | — | $1.06 | ▼ 1.85% | $0.84$12.23 |
| COCP Cocrystal Pharma Inc. Common Stock | $14.20M | — | $1.11 | ▼ 2.63% | $0.76$2.67 |
| AKTX Akari Therapeutics plc ADS | $14.14M | Infinity | $11.03 | ▲ 22.42% | $3.02$49.6 |
| KTTA Pasithea Therapeutics Corp. Common Stock | $14.82M | — | $0.5975 | ▲ 7.66% | $0.281$2.06 |
| HIND Vyome Holdings Inc. Common Stock | $15.02M | — | $2.2 | ▼ 0.23% | $1.75$10.97 |
| AEON AEON Biopharma Inc. Class A Common Stock | $13.80M | — | $0.3095 | ▲ 5.27% | $0.1772$1.45 |
| SCNX Scienture Holdings Inc. Common Stock | $15.14M | — | $0.3938 | ▲ 3.63% | $0.2382$2.6 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech NewsSeekingAlpha · 8/10/2026
Insider Activity
Insider Actions →- Yee John D. · June 4, 2026 · Grant25.0K
- Richey William Drake · June 4, 2026 · Grant25.0K
- Justin Trojanowski · March 31, 2026 · Grant22.0K
- Maestas Nicholas · March 31, 2026 · Grant140.0K
- Matthew Angel · March 24, 2026 · Buy231.5K @ $2.16
Institutional Ownership
March 31, 2026
- Total shares held
- 448.1K
- Total value held
- $734.8K
- Institutional holders
- 18
- Unknown233.9K
- Unknown87.0K
- Unknown39.1K
- Unknown33.2K
- Unknown17.9K
- Unknown14.1K
- Unknown11.4K
- Unknown4.5K
- Unknown2.8K
- Unknown2.1K
See the full, filterable feed with live charts on the MarketWall dashboard.